About CRISPR Medicine News

Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.

CLINICAL TRIALS
Indicator
IND Enabling
Phase I
Phase II
Phase III
Gastro-Intestinal Cancer, GI, (NCT04426669)
Sponsors:

Intima Bioscience, Inc.

IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine